EQL Pharma: Tracking well against long-term targets – Q1 preview
4 augusti, 07:27
4 augusti, 07:27
DNB Carnegie has published a new commissioned research report on EQL Pharma.
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.
4 augusti, 07:27
DNB Carnegie has published a new commissioned research report on EQL Pharma.
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.
Trumps handelskrig
Analys
Inflationen
Fonder
Aktieråd
Trumps handelskrig
Analys
Inflationen
Fonder
Aktieråd
1 DAG %
Senast
Asmodee
Idag, 07:32
Bättre resultat än väntat för Asmodee
OMX Stockholm 30
1 DAG %
Senast
2 593,76